Predictmedix raises $405,500 in private placement funding

Predictmedix AI Inc., based in Toronto, has announced the successful completion of the second round of its private placement, raising $405,500. This funding round saw significant investment from two German family offices, reflecting growing global confidence in the company's AI health solutions. The company issued 20,275,000 units at $0.02 each. Each unit includes a common share and a purchase warrant, allowing the holder to buy more shares at $0.05 each over the next two years. If the stock price increases significantly, Predictmedix can shorten the time period for exercising the warrants. This investment highlights increased interest from international institutions in Predictmedix’s technology and market potential. The company believes this funding marks a key moment as European investors recognize the benefits of its AI-driven health screening solutions. All shares from this placement are subject to a four-month hold period. Predictmedix is also preparing to close its final funding tranche soon. Predictmedix provides advanced health screening and remote patient care solutions. Their technology uses AI to analyze health data and detect various medical conditions, including drug or alcohol impairment and mental health issues.